Open Government Portal
Open Data Search has recently undergone significant changes. The search page has moved to search.open.canada.ca/opendata. Please update existing bookmarks accordingly.
Found 10 records similar to COVID-19 testing, screening and contact tracing
A near patient in vitro diagnostic device (IVDD) is used for: point-of-care testing in a health care setting (for example, doctor’s office, pharmacy, at the bedside) or self-testing ( for example, used by individuals at home). Typically, these rapid test devices are simple to use and provide visual or simple results within a short time.
Clinical trials, or investigational testing, are tests done to look at the safety and effectiveness of a medical device. These trials are authorized by Health Canada and are conducted on a device that may be used for another purpose or is not yet available in Canada.
Serological tests do not detect the virus itself. Instead, they detect the antibodies produced in response to an infection. Serology tests are also known as antibody tests. Serological tests are not appropriate for diagnosing COVID-19.
Testing for the virus, testing accuracy depends on when you get tested, and testing for antibodies.
Get a list of COVID-19 assessment centres. Before you go, you should check if: * The centre is open * They have drive-through or walk-in testing * They will test small children or babies * You need to make an appointment * You need to speak to a staff member about your condition (prescreening) All assessment centres will test you if you would like to be tested. Call the assessment centre or your local public health unit if you have questions. You do not need a health (OHIP) card for a test.
The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.
The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.
Coronavirus, COVID-19, pandemic, outbreak, testing, diagnosis, contact tracing, testing devices, point-of-care, POC, antigen, antibodies, molecular, FDA, non-laboratory use
This report presents evidence-informed recommendations for testing a vaccinated population and vaccinated individuals.
Nucleic acid-based testing is also called molecular testing, and is often called PCR. Molecular tests detect the virus genetic material (nucleic acids). Public health laboratories in Canada and around the world use nucleic acid-based testing to diagnose COVID-19 infection. This test is the gold standard to diagnose active COVID-19 infection in patients with symptoms.